Your session is about to expire
← Back to Search
Behavioral Intervention
Peer Interventions for Autism (PIPA Trial)
N/A
Recruiting
Research Sponsored by University of Kansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up secondary at baseline, 5 weeks, 12 weeks, and 16 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will evaluate interventions to improve communication in preschoolers with ASD who have limited or no spoken language. Kids with ASD can benefit from peer-mediated interventions, but 30% remain minimally-verbal. This study will test different approaches to help improve communication.
Who is the study for?
This trial is for preschoolers aged 3 to 6 with Autism Spectrum Disorder who have limited or no spoken language. They should be using or ready to use a speech-generating device and primarily speak English at home. Children must not have major medical conditions besides ASD, lack symbol discrimination skills, or have impairments that prevent play with peers.
What is being tested?
The study tests peer-mediated interventions (PMIs) like Stay-Play-Talk in various forms to improve social communication in children with autism. It uses a SMART design where kids start with basic PMI and may advance based on their response, potentially adding devices for communication or more direct teaching strategies.
What are the potential side effects?
Since the interventions are behavioral treatments involving peer interaction and communication devices rather than medications, traditional side effects are not expected. However, there might be variations in individual responses to the intervention's social and communicative demands.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ secondary at baseline, 5 weeks, 12 weeks, and 16 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~secondary at baseline, 5 weeks, 12 weeks, and 16 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in rate of peer-directed communication acts
Secondary study objectives
Aberrant Behavior Checklist
Change in expressive language
Change in expressive language multi-words
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
6Treatment groups
Experimental Treatment
Active Control
Group I: Stay_Play_Talk Plus Followed by Stay_Play_Talk Plus (SPT Plus Responders)Experimental Treatment1 Intervention
After being randomly assigned to the SPT Plus condition, these participants responded and therefore remained in this condition
Group II: Stay_Play_Talk Plus Followed by Randomization to Stay_Play_Talk Plus (SPT Plus - SPT Plus)Experimental Treatment1 Intervention
After being randomly assigned to the SPT Plus condition, these participants did not respond and were randomized to Stay_Play_Talk Plus in the second stage.
Group III: Stay_Play_Talk Plus Followed by Randomization to Stay_Play_Talk Advanced (SPT Plus - SPT Advanced)Experimental Treatment2 Interventions
After being randomly assigned to the SPT Plus condition, these participants did not respond and were randomized to Stay_Play_Talk Advanced condition in the second stage which incorporates direct instruction.
Group IV: Stay_Play_Talk Basic Followed by Randomization to Stay_Play_Talk Plus (SPT Basic - SPT Plus)Experimental Treatment2 Interventions
After being randomly assigned to the SPT Basic condition, these participants did not respond and were randomized to Stay_Play_Talk Plus in the second stage.
Group V: Stay-Play_Talk Basic Followed by Stay_Play_Talk Basic - (SPT Basic Responders)Active Control1 Intervention
After being randomly assigned to the SPT Basic condition, these participants responded and therefore remained in this condition
Group VI: Stay_Play_Talk Basic Followed by Randomization to Stay_Play_Talk Basic (SPT Basic - SPT BASIC)Active Control1 Intervention
After being randomly assigned to the SPT Basic condition, these participants did not respond but were randomized to stay in this condition to examine longer duration in this treatment.
Find a Location
Who is running the clinical trial?
Emory UniversityOTHER
1,701 Previous Clinical Trials
2,604,478 Total Patients Enrolled
23 Trials studying Autism Spectrum Disorder
21,455 Patients Enrolled for Autism Spectrum Disorder
University of KansasLead Sponsor
153 Previous Clinical Trials
331,635 Total Patients Enrolled
6 Trials studying Autism Spectrum Disorder
1,140 Patients Enrolled for Autism Spectrum Disorder
University of North CarolinaOTHER
170 Previous Clinical Trials
1,455,646 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I primarily speak English at home.I have physical or sensory issues that stop me from playing with others.I have no visual or hearing problems affecting my ability to follow instructions.
Research Study Groups:
This trial has the following groups:- Group 1: Stay-Play_Talk Basic Followed by Stay_Play_Talk Basic - (SPT Basic Responders)
- Group 2: Stay_Play_Talk Basic Followed by Randomization to Stay_Play_Talk Plus (SPT Basic - SPT Plus)
- Group 3: Stay_Play_Talk Basic Followed by Randomization to Stay_Play_Talk Basic (SPT Basic - SPT BASIC)
- Group 4: Stay_Play_Talk Plus Followed by Randomization to Stay_Play_Talk Advanced (SPT Plus - SPT Advanced)
- Group 5: Stay_Play_Talk Plus Followed by Stay_Play_Talk Plus (SPT Plus Responders)
- Group 6: Stay_Play_Talk Plus Followed by Randomization to Stay_Play_Talk Plus (SPT Plus - SPT Plus)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger